Velcade and Robitussin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Velcade (bortezomib) and Robitussin (guaifenesin). Common drug interactions include fatigue among females and arteriovenous fistula occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Velcade and Robitussin. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

What is Robitussin?

Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.



On Jul, 31, 2026

40 people who take Velcade and Robitussin together, and have interactions are studied.

Velcade and Robitussin drug interactions.

What are the common drug interactions of Velcade and Robitussin, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Neuropathy peripheral (surface nerve damage)
  3. Hypertension (high blood pressure)
  4. Pruritus (severe itching of the skin)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Weight increased
  7. Anaemia (lack of blood)
  8. Chest discomfort
  9. Chills (felling of cold)
  10. Colitis (inflammation of colon)

male:

  1. Arteriovenous fistula occlusion
  2. Anaemia (lack of blood)
  3. Brain natriuretic peptide increased
  4. Cardiac enzymes increased
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Chronic kidney disease
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Colitis (inflammation of colon)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Decreased appetite

What are the common drug interactions of Velcade and Robitussin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  2. Pneumonia

40-49:

n/a

50-59:

  1. Anaemia (lack of blood)
  2. Arteriovenous fistula occlusion
  3. Dyspnoea (difficult or laboured respiration)
  4. Chronic kidney disease
  5. Lacrimation increased
  6. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  7. Photosensitivity reaction
  8. Rash
  9. Renal failure (kidney dysfunction)

60+:

  1. Arteriovenous fistula occlusion
  2. Fatigue (feeling of tiredness)
  3. Cardiac enzymes increased
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Disease progression
  7. Ejection fraction decreased (systolic heart failure)
  8. Epistaxis (bleed from the nose)
  9. Erectile dysfunction
  10. Foot deformity (functional disability of foot)

What are the existing conditions these people have? *

  1. Cough: 3 people, 7.50%
  2. Constipation: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Velcade and Robitussin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Velcade and Robitussin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Robitussin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Velcade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robitussin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib and guaifenesin (the active ingredients of Velcade and Robitussin, respectively), and Velcade and Robitussin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: